Trial Profile
Effects of Intravenous Zoledronate on Bone Turnover and Bone Density Persist for at Least Five Years in HIV-Infected Men
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Aug 2020
Price :
$35
*
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 29 May 2012 New trial record